VectorialDATA
Stocks/BWXT

BWXT — BWX Technologies, Inc.

IndustrialsNorth AmericaUnited StatesBlockchain certified

Price when we picked it (Jun 8, 2026)

$189.31

Target: $238.00 (+25.7%)

P/E Ratio

50.5

P/E Forward

39.0

Dividend

0.58%

Market Cap

$17.2B

EPS

$3.75

Consensus

Buy

What they do

BWX Technologies, Inc. (NYSE: BWXT) manufactures ultra-high-precision nuclear components. It is, above all, a defense contractor: the sole supplier of the nuclear reactors that propel the U.S. Navy's submarines and aircraft carriers. HQ Lynchburg, Virginia.

Three businesses:

**

  • Government Operations / Naval Nuclear — the heart. BWXT designs and builds the naval nuclear reactors for the U.S. Navy. It's a structural monopoly**: the Navy has no other qualified supplier, and the programs (Columbia- and Virginia-class submarines, aircraft carriers) run for decades. Hence the giant backlog (~$8.65 billion) and the revenue predictability.

**

  • Advanced Technologies / micro-reactors — small, transportable nuclear reactors. It leads Project Pele**, the Department of Defense micro-reactor built to power remote bases, and participates in advanced-reactor projects for civilian and industrial use.

**

  • BWXT Medical — produces radioisotopes** and radiopharmaceuticals used in imaging diagnostics and cancer treatments. It's a high-margin healthcare business with growing demand.

Capital allocation: pays a small dividend (~0.58%, ~$1.08/year) and reinvests in capacity. Leadership: CEO Rex D. Geveden. Q1 2026: revenue $860.2M, EPS $1.12, backlog $8.65 billion.

Why we like it

BWXT at $189.31 means buying the only manufacturer of the reactors that power the U.S. Navy — a monopoly backed by defense budgets — with two growth options thrown in for free (micro-reactors and nuclear medicine). Specific reasons:

  • An irreplaceable monopoly: BWXT is the ONLY qualified supplier of U.S. naval reactors. The Navy can't switch suppliers — certifying another one would take decades and billions of dollars. That's a nearly unbreachable moat.
  • Defense-shielded revenue: the ~$8.65 billion backlog and 20-30 year submarine/carrier programs provide cash-flow visibility almost no industry has. It doesn't depend on the economic cycle; it depends on the U.S. military budget (which is rising).
  • The nuclear renaissance, low-risk version: instead of betting on a reactor startup, you buy the established supplier that already builds military-grade reactors and is expanding into micro-reactors (Project Pele) and civilian power.
  • Nuclear medicine (optionality): BWXT Medical rides the theranostics boom — isotopes to detect and treat cancer — a high-margin, structurally growing market.
  • AI's hunger for electricity: data centers' appetite for power is re-rating everything nuclear, and BWXT is a core supplier. Analysts: Buy, average target ~$238 (~+26%).

Key Risk

Risks:

  • Dependence on the U.S. defense budget — the #1: most revenue comes from the Navy. A military spending cut, a delay in submarine/carrier programs, or a budget fight in Congress hits directly.
  • High valuation: at ~50x earnings, the price already assumes growth; if execution disappoints, there's room for a correction.
  • Single-customer concentration: when your main customer is one buyer (the U.S. government), you lose pricing power and depend on its agenda.
  • Executing complex programs: building nuclear reactors is about as hard and regulated as it gets; cost overruns, delays or quality problems can eat the margin.
  • A small dividend (~0.58%): the dividend income is symbolic; the thesis is growth, not income.
  • New businesses without proven scale: micro-reactors and nuclear medicine are promising but still small next to the naval business; they'll take time to move the needle.

This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.

Vectorial Data picked BWXT on Jun 8, 2026 at $189.31.

Full Research

BWX Technologies (BWXT) — Full Research

Price: $189.31 | P/E TTM: ~50.5x | Div Yield: ~0.58% | Market Cap: ~$17.2B USD


What is BWXT?

The sole manufacturer of the nuclear reactors that propel the U.S. Navy's submarines and aircraft carriers. A monopoly by design, backed by defense budgets. HQ Lynchburg, Virginia.

3 Businesses

SegmentWhat it isNote
Naval NuclearReactors for the U.S. Navy (submarines, carriers)Monopoly, backlog ~$8.65B
Advanced Tech / micro-reactorsProject Pele (DoD), advanced reactorsGrowth
BWXT MedicalRadioisotopes for diagnostics and cancerHigh margin

Q1 2026

MetricQ1 2026
Revenue$860.2M
EPS$1.12
Backlog$8.65 billion

Capital Allocation

  • Dividend: ~$1.08/year (~0.58%).
  • Reinvestment in capacity.

Leadership

  • CEO: Rex D. Geveden.

Anchor Fact

Every nuclear submarine and aircraft carrier in the U.S. Navy carries a reactor inside — and there is ONE company in the world authorized to build them: BWXT. The Navy has no 'plan B': certifying another supplier would take decades. That gives BWXT military contracts running 20 or 30 years and an order backlog of ~$8.65 billion, no matter whether the economy rises or falls.

Top 5 Risks

  • Dependence on the U.S. defense budget
  • High valuation (~50x)
  • Single-customer concentration (the government)
  • Executing complex nuclear programs
  • Symbolic dividend (~0.58%) — the thesis is growth

Analyst Consensus

  • Rating: Buy
  • Average target: ~$238 (~+26% from $189.31)

The Thesis in One Line

The irreplaceable monopoly on the U.S. Navy's reactors, shielded by defense budgets, with micro-reactors and nuclear medicine as growth options.

Research date: Jun 8, 2026 | Next review: Dec 2026

This is not financial advice.

More picks in Industrials

See all Industrials picks →

More picks from United States

See all picks from United States →
Researched: Jun 8, 2026Updated: Jun 8, 2026Next review: Dec 8, 2026

This is not financial advice. Consult a certified financial advisor.

The author may hold positions in the securities discussed.

Past performance does not guarantee future results.